Dashboard
Manage Tickers

CERTCertara, Inc.

Nasdaq certara.com


$ 15.62 $ 0.44 (2.9 %)    

Monday, 15-Jul-2024 13:37:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 495.89 $ -0.84 (-0.17 %)
DIA $ 401.74 $ -0.86 (-0.21 %)
SPY $ 561.18 $ -1.00 (-0.18 %)
TLT $ 92.82 $ -0.14 (-0.15 %)
GLD $ 223.91 $ 0.49 (0.22 %)
$ 15.18
$ 15.28
$ 0.00 x 0
$ 0.00 x 0
$ 15.28 - $ 15.77
$ 11.81 - $ 19.87
743,103
na
2.42B
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

keybanc-maintains-overweight-on-certara-lowers-price-target-to-20
Keybanc Maintains Overweight on Certara, L...
07/11/2024 11:09:29

Keybanc analyst Scott Schoenhaus maintains Certara (NASDAQ:CERT) with a Overweight and lowers the price target from $23 to $20.

jmp-securities-reiterates-market-perform-on-certara
JMP Securities Reiterates Market Perform o...
07/10/2024 14:24:46

JMP Securities analyst Constantine Davides reiterates Certara (NASDAQ:CERT) with a Market Perform.

certara-reiterates-full-year-2024-guidance-excluding-chemaxon
Certara Reiterates Full Year 2024 Guidance...
07/09/2024 20:48:15

Certara, excluding Chemaxon, is reiterating 2024 revenue, adjusted EBITDA margin, and adjusted diluted earnings per share guida...

certara-agrees-to-acquire-cheminformatics-software-provider-chemaxon-no-terms-disclosed
Certara Agrees To Acquire Cheminformatics ...
07/09/2024 20:46:41

The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing con...

barclays-maintains-equal-weight-on-certara-lowers-price-target-to-16
Barclays Maintains Equal-Weight on Certara...
06/28/2024 15:44:10

Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the price target from $18 to $16.

certara-launches-coauthor-regulatory-writing-software
Certara Launches CoAuthor Regulatory Writi...
06/17/2024 12:07:18

certara-sees-fy24-adj-eps-041-046-vs-043-est-revenue-385m-400m-vs-38845m-est
Certara Sees FY24 Adj. EPS $0.41-$0.46 vs ...
05/07/2024 20:38:13

certara-q1-2024-gaap-eps-010-inline-sales-96654m-beat-93637m-estimate
Certara Q1 2024 GAAP EPS $0.10, Inline, Sa...
05/07/2024 20:37:23

Certara (NASDAQ:CERT) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. The company rep...

certara-shares-are-trading-higher-after-keybanc-upgraded-the-stock-from-sector-weight-to-overweight
Certara shares are trading higher after Ke...
04/10/2024 11:13:17

keybanc-upgrades-certara-to-overweight-announces-23-price-target
Keybanc Upgrades Certara to Overweight, An...
04/10/2024 08:38:49

Keybanc analyst Scott Schoenhaus upgrades Certara (NASDAQ:CERT) from Sector Weight to Overweight and announces $23 price tar...

decoding-4-analyst-evaluations-for-certara
Decoding 4 Analyst Evaluations For Certara
04/04/2024 12:01:43

jmp-securities-initiates-coverage-on-certara-with-market-perform-rating
JMP Securities Initiates Coverage On Certa...
04/04/2024 08:54:21

JMP Securities analyst Constantine Davides initiates coverage on Certara (NASDAQ:CERT) with a Market Perform rating.

ubs-maintains-neutral-on-certara-raises-price-target-to-20
UBS Maintains Neutral on Certara, Raises P...
03/01/2024 16:38:11

UBS analyst Dan Leonard maintains Certara (NASDAQ:CERT) with a Neutral and raises the price target from $17 to $20.

analyst-scoreboard-4-ratings-for-certara
Analyst Scoreboard: 4 Ratings For Certara
03/01/2024 16:00:59

jefferies-maintains-hold-on-certara-raises-price-target-to-155
Jefferies Maintains Hold on Certara, Raise...
03/01/2024 12:23:05

Jefferies analyst David Windley maintains Certara (NASDAQ:CERT) with a Hold and raises the price target from $14 to $15.5.

certara-sees-2024-adj-eps-041-046-vs-048-est-revenue-385m-400m-vs-36395m-est
Certara Sees 2024 Adj. EPS $0.41-$0.46 vs ...
02/29/2024 21:12:14

certara-q4-2023-adj-eps-0090-misses-0110-estimate-sales-88m-beat-86596m-estimate
Certara Q4 2023 Adj EPS $0.090 Misses $0.1...
02/29/2024 21:11:17

Certara (NASDAQ:CERT) reported quarterly earnings of $0.090 per share which missed the analyst consensus estimate of $0.110 by ...

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

leerink-partners-initiates-coverage-on-certara-with-market-perform-rating-announces-price-target-of-19
Leerink Partners Initiates Coverage On Cer...
02/26/2024 13:36:49

Leerink Partners analyst Michael Cherny initiates coverage on Certara (NASDAQ:CERT) with a Market Perform rating and announc...

tax-season-is-here-meet-the-new-federal-program-that-can-eat-away-at-tax-preparation-companies
Tax Season Is Here: Meet The New Federal P...
01/30/2024 19:31:06

New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)